Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jan 1;9(2):440–449. doi: 10.7150/jca.21560

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Ivyspring International Publisher

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

The effect of LCL-SIM treatment on the MDA levels in C26 colon carcinoma. The results are expressed as mean ± SD of three independent measurements and compared with control tumors levels of MDA; Control - untreated group (group treated with PBS); SIM - group treated with 5 mg/kg free SIM at days 8 and 11 after tumor cell inoculation; LCL-SIM 5 mg/kg - group treated with 5 mg/kg LCL-SIM at days 8 and 11 after tumor cell inoculation; To compare the effects of each treatment on the tumor levels of the MDA with its control levels, one-way ANOVA with Dunnett's Test for multiple comparisons was used and the P values are indicated as follows:** (p<0.01), **** (p<0.0001).